首页> 外文OA文献 >Amyloid beta-peptides 1-40 and 1-42 form oligomers with mixed beta-sheets
【2h】

Amyloid beta-peptides 1-40 and 1-42 form oligomers with mixed beta-sheets

机译:淀粉样β肽1-40和1-42形成具有混合β-折叠的低聚物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two main amyloid-beta peptides of different length (A beta(40) and A beta(42)) are involved in Alzheimer's disease. Their relative abundance is decisive for the severity of the disease and mixed oligomers may contribute to the toxic species. However, little is know about the extent of mixing. To study whether A beta(40) and A beta(42) co-aggregate, we used Fourier transform infrared spectroscopy in combination with C-13-labeling and spectrum calculation and focused on the amide I vibration, which is sensitive to backbone structure. Mixtures of monomeric labeled A beta(40) and unlabeled A beta(42) (and vice versa) were co-incubated for similar to 20 min and their infrared spectrum recorded. The position of the main C-13-amide I' band shifted to higher wavenumbers with increasing admixture of C-12-peptide due to the presence of C-12-amides in the vicinity of C-13-amides. The results indicate that A beta(40) and A beta(42) form mixed oligomers with a largely random distribution of A beta(40) and A beta(42) strands in their beta-sheets. The structures of the mixed oligomers are intermediate between those of the pure oligomers. There is no indication that one of the peptides forces the backbone structure of its oligomers on the other peptide when they are mixed as monomers. We also demonstrate that isotope-edited infrared spectroscopy can distinguish aggregation modulators that integrate into the backbone structure of their interaction partner from those that do not. As an example for the latter case, the pro-inflammatory calcium binding protein S100A9 is shown not to incorporate into the b-sheets of A beta(42).
机译:两种不同长度的主要淀粉样β肽(A beta(40)和A beta(42))与阿尔茨海默氏病有关。它们的相对丰度对疾病的严重程度具有决定性作用,混合的低聚物可能是有毒物质的原因。然而,对混合程度了解甚少。为了研究A beta(40)和A beta(42)是否共聚集,我们使用傅里叶变换红外光谱技术结合C-13标记和光谱计算,重点研究对骨架结构敏感的酰胺I振动。共孵育单体标记的A beta(40)和未标记的A beta(42)的混合物(反之亦然)约20分钟,并记录其红外光谱。随着C-12-酰胺在C-13-酰胺附近的存在,随着C-12-肽混合的增加,主要的C-13-酰胺I'带的位置移向更高的波数。结果表明,A beta(40)和A beta(42)形成了混合的低聚物,其中在其β-折叠层中A beta(40)和A beta(42)链的分布非常随机。混合低聚物的结构介于纯低聚物的结构之间。没有迹象表明,当一个肽作为单体混合时,其中一个肽会在另一个肽上强迫其寡聚物的骨架结构。我们还证明了同位素编辑的红外光谱技术可以将聚集到其相互作用伙伴的骨架结构中的聚集调节剂与未聚集到其中的聚集调节剂区分开。作为后一种情况的一个例子,促炎性钙结合蛋白S100A9显示未结合到A beta(42)的b-折叠中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号